12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·04/02/2026 12:05:33
Listen to the news
Gainers
Catheter Precision (AMEX:VTAK) shares increased by 11.7% to $1.05 during Thursday's pre-market session. The market value of their outstanding shares is at $2.2 million. As per the press release, Q4 earnings came out 2 days ago.
Cocrystal Pharma (NASDAQ:COCP) stock increased by 9.8% to $1.12. The company's market cap stands at $14.0 million. The company's, Q4 earnings came out 2 days ago.
Intelligent Bio Solutions (NASDAQ:INBS) shares moved upwards by 8.97% to $3.4. The market value of their outstanding shares is at $6.2 million.
Sionna Therapeutics (NASDAQ:SION) stock rose 8.95% to $45.0. The company's market cap stands at $1.8 billion.
Profusa (NASDAQ:PFSA) shares moved upwards by 8.51% to $0.63.
Century Therapeutics (NASDAQ:IPSC) stock moved upwards by 8.21% to $2.37. The company's market cap stands at $393.5 million.
Losers
Inovio Pharmaceuticals (NASDAQ:INO) shares fell 21.3% to $1.37 during Thursday's pre-market session. The company's market cap stands at $120.2 million.
CDT Equity (NASDAQ:CDT) stock declined by 20.59% to $4.05. The company's market cap stands at $24.0 million.
Cyclerion Therapeutics (NASDAQ:CYCN) shares decreased by 20.07% to $5.1. The company's market cap stands at $24.2 million.
HCW Biologics (NASDAQ:HCWB) shares decreased by 15.74% to $0.25. The company's market cap stands at $1.0 million. As per the news, the Q4 earnings report came out 2 days ago.
Onconetix (NASDAQ:ONCO) shares fell 15.21% to $1.59. The market value of their outstanding shares is at $1.2 million.
Enveric Biosciences (NASDAQ:ENVB) shares decreased by 13.83% to $1.84. The company's market cap stands at $2.9 million. As per the press release, Q4 earnings came out 4 days ago. See Also:www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.